Gallopamil hydrochloride Methoxyverapamil hydrochloride,98.0%
产品编号:Bellancom-14276A| CAS NO:16662-46-7| 分子式:C28H41ClN2O5| 分子量:521.09
Gallopamil hydrochloride (Methoxyverapamil hydrochloride) 是一种维拉帕米的甲氧基衍生物 (methoxy derivative of verapamil),也是一种苯基烷基胺钙 (phenylalkylamine calcium) 拮抗剂。Gallopamil hydrochloride 以浓度依赖性方式抑制酸分泌,IC50 为 10.9 μM。Gallopamil hydrochloride 是一种有效的抗心律不齐和血管扩张剂。
本网站销售的所有产品仅用于工业应用或者科学研究等非医疗目的,不可用于人类或动物的临床诊断或者治疗,非药用,非食用,
Gallopamil hydrochloride Methoxyverapamil hydrochloride
产品介绍 | Gallopamil hydrochloride (Methoxyverapamil hydrochloride) 是一种维拉帕米的甲氧基衍生物 (methoxy derivative of verapamil),也是一种苯基烷基胺钙 (phenylalkylamine calcium) 拮抗剂。Gallopamil hydrochloride 以浓度依赖性方式抑制酸分泌,IC50 为 10.9 μM。Gallopamil hydrochloride 是一种有效的抗心律不齐和血管扩张剂。 | ||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
生物活性 | Gallopamil hydrochloride (Methoxyverapamil hydrochloride), a methoxy derivative of Verapamil, is a phenylalkylamine calcium antagonist. Gallopamil hydrochloride inhibits acid secretion in a concentration-dependent manner with an IC50 of 10.9 μM. Gallopamil hydrochloride is a potent antiarrhythmic and vasodilator agent. | ||||||||||||||||
体外研究 | |||||||||||||||||
体内研究 |
Gallopamil hydrochloride (Methoxyverapamil hydrochloride; i.v.; 0.2 mg/kg; for 5 min) markedly reduces ventricular tachycardia (VT) and totally prevents fibrillation (VF). Gallopamil significantly reduces systolic and diastolic blood pressure measured 5 min after injection without markedly influencing heart rate. 西域 has not independently confirmed the accuracy of these methods. They are for reference only.
| ||||||||||||||||
体内研究 |
Gallopamil hydrochloride (Methoxyverapamil hydrochloride; i.v.; 0.2 mg/kg; for 5 min) markedly reduces ventricular tachycardia (VT) and totally prevents fibrillation (VF). Gallopamil significantly reduces systolic and diastolic blood pressure measured 5 min after injection without markedly influencing heart rate. 西域 has not independently confirmed the accuracy of these methods. They are for reference only.
| ||||||||||||||||
性状 | Solid | ||||||||||||||||
溶解性数据 |
In Vitro:
DMSO : 100 mg/mL (191.91 mM; Need ultrasonic) 配制储备液
*
请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液;一旦配成溶液,请分装保存,避免反复冻融造成的产品失效。 In Vivo:
请根据您的实验动物和给药方式选择适当的溶解方案。以下溶解方案都请先按照 In Vitro 方式配制澄清的储备液,再依次添加助溶剂:
——为保证实验结果的可靠性,澄清的储备液可以根据储存条件,适当保存;体内实验的工作液,建议您现用现配,当天使用;
以下溶剂前显示的百
| ||||||||||||||||
运输条件 | Room temperature in continental US; may vary elsewhere. | ||||||||||||||||
储存方式 |
4°C, sealed storage, away from moisture *In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture) | ||||||||||||||||
参考文献 |
|
WGK德国 | 3 |
---|

匹配竞争对手的价格

效率为先

专业经验 贴心服务

50000+库存